safest place to get retatrutide Is the Next Longevity Drug? What Experts Say About the Weight Loss Trend We get asked about this

Retatrutide Weight Loss Results Phase 2 trial data published in 2023 showed that retatrutide at the 12 mg dose produced an average weight loss of approximately 24.2% at 24 weeks , with projections suggesting that the loss could approach 2829% at 48 weeks based on the observed trajectory

Classic anticonvulsants such as pheytoin and carbamazepine had a relatively high EID ( 1:50,000)

Current Availability and Regulatory Status in the UK Retatrutide is not approved by the MHRA or EMA as of 2025 and cannot be legally prescribed in the UK

Plan for Social Meals and Busy Days Eating out, celebrations, or travel can sometimes make routines feel less predictable